|
Straight
Track #44 Should You Take Health Advice
From Drug Ads? Hoey
& Farina
info@felahfd.com
1-888-425-1212
Good health! It's something we all wish for our family, our friends and ourselves. We ran across this interesting article in the October 2000 issue of Consumer Reports and thought our railroad friends and their families might enjoy reading them.
The following is another in a series of health-related articles that have been featured in Straight Track.
Should
You Take Health Advice
From Drug Ads
By Marvin M. Lipman, M.D.
OCTOBER 2000
CONSUMER REPORTS ON HEALTH (page 11)
Like
many primary-care physicians, I have been besieged in recent years by
patients requesting prescriptions for drugs they’ve seen advertised on
TV or in print. Those
direct-to-consumer (DTC) ads seldom provide reliable medical guidance.
They may suggest a need where none exists, minimize side effects,
or talk about the drug’s benefits in isolation, rather than in the
context of other available medications and lifestyle treatments.
Some examples:
-
A
schoolteacher, 32, with hay fever wanted to try Claritin, a nonsedating prescription antihistamine she had seen
advertised in a magazine. I
pointed out that she’d gotten along fine on diphenhydramine (Benadryl) for years at a fraction of what it would cost her to take Claritin.
-
An
accountant, 68, with Type 2 diabetes wanted to know why I wasn’t
treating him with “that new drug, Glucophage.”
I explained that I had decided against using it because his
marginal kidney function might put him at increased risk of a
life-threatening complication associated with that drug.
He quickly withdrew the request.
-
A
stockbroker, 47, with a long-standing fungus infection of his toenails
asked for Lamisil, an oral
antifungal medicine he had seen advertised on television, because “I
don’t want to hide my toes under the sand anymore.”
I explained about possible liver toxicity, but he insisted.
I turned him down. His dermatologist didn’t.
Treatment was stopped after one month because his liver-function
tests became abnormal. They
returned to normal after the medication was stopped.
CAUGHT
IN THE STAMPEDE
Until
the mid-1980s, federal government restrictions discouraged drug
manufacturers from advertising prescription medications directly to the
public. Then in 1985 the Food
and Drug Administration (FDA) decided to allow the pharmaceutical industry
to bypass the physician and communicate directly with the public, as long
as certain consumer safeguards were met.
Under pressure from industry, the safe-guards – which included
government screening of advertisements prior to release and the full
disclosure of side effects – were relaxed in 1977.
Those
deregulatory changes unleashed a stampede of prescription-drug
advertisements aimed at consumers to boost the demand for those drugs.
The pharmaceutical industry poured roughly $2 billion into DTC
advertising in 1999 – a 40 percent increase over the previous year –
and is expected to raise it to $7.5 billion by 2005.
SECOND-GUESSING
THE DOCTOR
No
studies have evaluated whether DTC ads actually lead to better health
care, but they’ve certainly altered the doctor-patient relationship.
A survey of California residents found that advertisements
prompted 35 percent to ask their doctor for more information about a
drug; nearly 20 percent of them directly requested the drug.
Of that group, almost half said they’d probably be disappointed
if their prescription request weren’t granted, and some said they might
switch doctors if the advertised drug were not prescribed.
For
the physician this could mean increasing pressure to acquiesce to those
requests or risk alienating patients by refusing them.
Concerned that DTC ads are usurping their medical authority, many
physicians don’t think those ads are a good idea.
Nonetheless, by prompting patients to see their doctor more often,
these ads have also boosted physician income.
THE
NEED FOR SKEPTICISM
Consumers
should remember that advertising is advertising, whether it’s selling a
car or a drug. The thrust of
an ad may seem to be informational, but the information has been selected
for the purpose of selling a product and is not necessarily dependable.
Ads typically emphasize benefits and minimize drawbacks, so it’s
important to seek an unbiased information source.
According
to an FDA survey, roughly one in three adults
believe—incorrectly—that only the safest drugs are allowed to
advertise. About the same
number totally ignore the brief summary of side effects that accompanies
many DTC advertisements.
When
you’re reading or listening to a drug ad, watch out for those ads that:
-
Imply
that the drug is always effective.
Few if any clinical studies have ever shown 100 percent
efficacy for any medication.
-
Gloss
over side effects, present them in highly technical language, or
announce or display them so quickly that they’re unintelligible. All medications have side effects; warnings that you don’t
understand are useless.
-
Offer
inducements such as rebates or reimbursement for the cost of seeing a
physician. Those initial
incentives may not be such a bargain, since many advertisements are
for expensive drugs that require long-term use.
Marvin
M. Lipman, M.D., has been Consumers Union’s chief medical adviser since
1967. He is a diplomate of
the American Board of Internal Medicine (certified in endocrinology and
metabolism) and is clinical professor of medicine emeritus at New York
Medical College.
[top]
|